Expand RZLT Menu
RZLT MENU

RZLT Stock Posts


Unusual Option Volume

RZLT Rezolute - Common (Nv)4.22-0.01 (-0.2%)

Rezolute - Common (Nv) trades 2,575 contracts. The highest volume is in the 15-Jan-27 10 calls, which is 137.0% above the current price. News: Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Unusual Option Volume

RZLT Rezolute - Common (Nv)3.89-0.12 (-3.0%)

Rezolute - Common (Nv) trades 4,100 contracts. The highest volume is in the 16-Oct-26 5 calls, which is 28.5% above the current price. News: Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
Unusual Option Volume

RZLT Rezolute - Common (Nv)5.06+0.40 (+8.6%)

Rezolute - Common (Nv) trades 3,762 contracts.
Unusual Option Volume

RZLT Rezolute - Common (Nv)4.98+0.53 (+11.9%)

Rezolute - Common (Nv) trades 2,715 contracts. The company has the following event: BTIG Virtual Biotechnology Conference between Jul 28, 2026 and Jul 29, 2026. News: Rezolute to Participate in the BTIG Virtual Biotechnology Conference
Unusual Option Volume

RZLT Rezolute - Common (Nv)5.05+0.26 (+5.4%)

Rezolute - Common (Nv) trades 2,448 contracts.
Unusual Option Volume

RZLT Rezolute - Common (Nv)4.18+0.57 (+15.8%)

Rezolute - Common (Nv) trades 3,019 contracts. The company has the following event: Jefferies Global Healthcare Conference between Jun 2, 2026 and Jun 4, 2026. News: Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Market Data Delayed 15 Minutes